INTRODUCTION {#sec1-1}
============

*Salmonella typhi* is a gram-negative enteric bacillus, (Enterobacteriaceae) a nonspore forming, motile, facultative anaerobe. *S. typhi* is a causative agent of typhoid or enteric fever which is characterized by the sudden onset of a sustained and systemic fever, severe headache, nausea, diarrhoea, and loss of appetite. The mortality rate of untreated cases ranges from 12% to 30% while that of treated cases is about 1%.\[[@ref1][@ref2]\] Typhoid fever is a major cause of morbidity and mortality in the developing world. This systemic illness, caused by *S. typhi*, tends to proceed to life-threatening complications and so it is necessary to institute appropriate therapy as early as possible. Since *S. typhi* has developed resistance to ampicillin, chloramphenicol, and cotrimoxazole, ciprofloxacin has been the drug of choice for treatment. This antibiotic targets the DNA gyrase enzyme of the bacterium and inactivates it. Recently, there have been reports of treatment failure with this antibiotic, and a concurrent rise in minimum inhibitory concentrations (MICs). Although outright resistance has not yet been reported, the steady increase in MIC indicates that this may occur in the near future.\[[@ref3]\]

Treatment regimens based on traditional medicine (including herbal medicine) remains widespread in developing countries and is finding greater acceptance in developed countries.\[[@ref4]\] Traditional medicine can be an effective alternative source for antibiotic resistant strains, particularly after the recent dramatic failures of antibiotics against multidrug-resistant microorganisms.\[[@ref5]\] Antimicrobial compounds isolated from traditional medicines shows activity after long term use and consumption in high concentration. There are possibilities of developing antimicrobial compounds with no more resistance if already standardized synthetic antibiotics are used in combination with isolated active constituents of herbals. We explore such an approach in this study by assessing the antimicrobial interaction effect of the phenolic, nonphenolic fractions, and volatile oil of *Oreganum vulgare* Linn. (Lamiaceae) with a standard synthetic antibiotic ciprofloxacin.

MATERIALS AND METHODS {#sec1-2}
=====================

Plant material {#sec2-1}
--------------

The freeze dried leaves of *O. vulgare* Linn. were procured from Aum Agreefresh Pvt. Ltd., Vadodara, Gujarat and were identified by the same company. The voucher specimen (Pcog1101) was deposited in Department of Pharmaceutical sciences, Guru Jambheshwar University of Science and Technology for future references.

Bacterial strains and antibiotics {#sec2-2}
---------------------------------

The bacterial strain used was *S. typhi*, isolated clinically from three different patients at the Civil Hospital, Fatehabad, Haryana, India. Bismuth sulphite agar media (Hi-media, India) was used for colony growth from blood sample. The bacterial strains were grown to exponential phase in nutrient broth (NB) at 37°C for 24 h. NB was used (Hi-media, India). Ciprofloxacin (Hi-Media, India) was used as standard antibiotic. All other chemicals used were of analytical grade.

Preparation of extracts {#sec2-3}
-----------------------

A total of 500 g of the leaves was placed in a closed flask with chloroform and after 24 h, filtered, and concentrated in rotary vacuum to yield 12.5 g of green colored paste-like extract.\[[@ref6]\]

In order to separate the phenolic from nonphenolic fraction of the chloroform extract, a liquid-liquid extraction was done. In a seperatory funnel, 2 g of the extract was diluted in 40 mL of chloroform and washed 3 times with 120 mL of 0.1 N sodium hydroxide. The chloroform phase was separated and was concentrated to obtain the crude nonphenolic fraction. To further purify this fraction, 0.3 g of it was diluted in ethanol and centrifuged at 3600 × g at 10°C for 15 min. Ethanol was concentrated from the supernatant to obtain purified nonphenolic fraction. The basic aqueous phase was acidified with 6N HCl to pH 3.0 and 40 mL of chloroform was added to extract the phenolic fraction. The phenolic fraction was dissolved in chloroform and separated by preparative thin layer chromatography on silica gel-G eluting with benzene-methanol 95:5.\[[@ref6]\]

Extraction of volatile oil {#sec2-4}
--------------------------

Volatile oil was extracted from freeze dried leaves (1000 g) by hydrodistillation method using clevenger\'s apparatus. The yellowish oil (16.6 mL, yield = 1.66% v/w) obtained was separated from aqueous phase and dried over anhydrous sodium sulphate and stored at 4°C until used.

GC-MS analysis of volatile oil {#sec2-5}
------------------------------

The oil sample was diluted with hexane in a ratio of 1:100 and used for the further analysis. The quantitative analysis was done with the help of chromatographer in gas phase (Agilent 7890A GC system) equipped with MS detector (5975C inert XL EI/CI MSD), HP-5MS capillary column (Agilent 19091S-433: 1548.52849 HP-5MS 5% Phenyl Methyl Silox) having dimensions 30 m × 250 μm × 0.25 μm. The column temperature was pre programmed from an initial 80°C upto 300°C. The temperature of the injector was fixed at 270°C. The debit of gas (helium) vector was fixed to 1mL/min and split injection with split ratio 50:1. The volume of injected sample was 2 μL of diluted oil in hexane (10%). The components were identified based on comparison of their relative retention time and mass spectra with those of standards, W9N08.L library data of the GC-MS system, and literature data.

Isolation of bacteria from clinical blood samples {#sec2-6}
-------------------------------------------------

All the three samples of blood obtained from patients suffering from typhoid were properly labelled and their isolation was carried out by serial dilution method. From each sample, 1 mL of the blood was dissolved in 9 mL of 0.1% saline and then was serially diluted up to twofold dilutions. Then, 1 mL of blood from each dilution was poured in different sterilized petri-plates. The plates were labelled to indicate respective dilutions. Bismuth sulphite agar media was poured in the plates and allowed to solidify. After solidification of the media, plates were kept in an incubator for 48 h at 37°C. After 2 days, black color colonies appeared on the plates and they were then transferred to a liquid nutrient broth medium.\[[@ref7][@ref8]\] The colonies were subjected to carbohydrate utilization involving glucose, lactose, sucrose, manitol, salicin, dulcitol, and melibiose fermentation test which differentiate *S. Enteritidis* and *S. typhimurium*.\[[@ref9]\] The broth culture was incubated at 35°C until it achieved the turbidity of the 0.5 McFarland standards (usually takes 2-6 h). This results in a suspension containing approximately 1-2 × 10^8^ cfu/mL. The turbidity of the actively growing broth culture was adjusted with sterile broth to obtain turbidity comparable to that of the 0.5 McFarland standards.

MIC determination by spectrophotometric evaluation and growth curve {#sec2-7}
-------------------------------------------------------------------

MIC was determined by a modified method as previously described.\[[@ref10][@ref11]\] The concentration of stock solutions of phenolic and nonphenolic fractions was 10 mg/mL, and that of ciprofloxacin was 0.25 mg/mL in DMSO. A total of 0.5 mL of phenolic and nonphenolic fractions and volatile oil were mixed with 0.5 mL of ciprofloxacin, respectively. MIC of phenolic, nonphenolic fraction, volatile oil, and ciprofloxacin was determined using twofold serial dilution method. For determination of interaction effect of phenolic, nonphenolic fractions, and volatile oil, 0.5 mL of respective test samples were mixed with 0.5 mL of ciprofloxacin stock solution. Tubes containing only bacterial suspensions and nutrient broth were used as positive controls and negative controls were the tubes with only nutrient broth.

Optical Densities (ODs) were measured at 35°C using Thermo Scientific 2000/2000 C nanodrop spectrophotometer at 405 nm. OD of each replicate at before incubation (T~0~) was subtracted from OD after incubation at 37°C (T~24~). The adjusted OD of each control tube was then assigned a value of 100% growth. The percent inhibition of growth was thus determined using the formula:

Percent inhibition = 1-(OD of tube containing test solution/OD of corresponding control tube) ×100.

The MIC is reported as the lowest concentration of test material which results in 100% inhibition of growth of the test organism.

Evaluation of fractional inhibitory concentration index {#sec2-8}
-------------------------------------------------------

The FICI was calculated by dividing the MIC of the combination of phenolic fraction, nonphenolic fraction, volatile oil, and reference antibiotic respectively.\[[@ref12]\]

FIC of volatile oil = MIC of volatile oil in combination with antibiotic drug/MIC of volatile oilFIC of phenolic fraction = MIC of phenolic fraction in combination with antibiotic drug/MIC of phenolic fractionFIC of nonphenolic fraction = MIC of nonphenolic fraction in combination with antibiotic drug/MIC of nonphenolic fractionFIC of antibiotic drug = MIC of antibiotic drug with particular fraction/MIC of drugFICI (volatile oil) = FIC of volatile oil + FIC of antibiotic drugFICI (phenolic fraction) = FIC of phenolic fraction + FIC of antibiotic drugFICI (nonphenolic fraction) = FIC of nonphenolic fraction + FIC of antibiotic drug.

RESULTS AND DISCUSSION {#sec1-3}
======================

Thirty-five compounds were identified from volatile oil in different proportions. The major constituent was identified as carvacrol (86.5%) followed by π-cymene (7.24%) and 4-Terpineol (0.56%). Inhibitory effects of *O. vulgare* essential oils and of carvacrol against gram-negative bacteria have been confirmed.\[[@ref13]\] Tables [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"} and [Figure 1](#F1){ref-type="fig"} represent MIC in mg/mL. Volatile oil alone shows significant inhibitory activity against all the three clinical isolates of *S. typhi* at 0.00015, 0.078, and 0.00448 mg/mL, respectively, while MIC of phenolic fraction was 0.156, 0.312, and 0.03900 mg/mL, respectively. The MIC value is higher for nonphenolic fraction as it shows inhibitory activity at 1.25, 0.312, and 0.625 mg/mL, respectively. The interaction effect studies represented interesting results as addition of volatile oil in ciprofloxacin decreased the MIC of ciprofloxacin to 0.00007, 0.00122, and 0.00061 mg/mL, respectively in three bacterial isolates. Similar synergistic results were obtained for phenolic fraction and volatile oil of which carvacrol, a phenol, is the major component of oil. The phenols are known to damage the membrane of microorganisms first, making the cells more sensitive.\[[@ref14]\] As a consequence, impairment of proton pumps and loss of H^+^-ATPase in damaged membranes can cause disruption in the normal cellular function of the microorganism and therefore lead to cell death. Further, the acidic nature of phenols containing extracts themselves at higher concentrations may create a low-pH microenvironment due to proton donation and cell membrane disruption due to stacking,\[[@ref15]\] which is likely to be more effective than low pH alone. Several authors observed that volatile oils are rich in phenolic compounds possessing high levels of antimicrobial activity.\[[@ref16][@ref17]\] The FIC and FICI calculated are listed in [Table 3](#T3){ref-type="table"}. The FIC of volatile oil for all the three isolates were 0.466, 0.015, and 0.125, respectively; 0.007, 2.000, and 0.248 for phenolic fractions; and that of 0.500, 2.003, and 0.249 for nonphenolic fractions, respectively. The FICI was calculated to describe the interaction studies. Synergy is defined as an FICI of ≤ 0.5. Indifference was defined as an FICI of ≥ 0.5 but of ≤ 4.0. Antagonism was defined as an FICI of \> 4.0.\[[@ref18]\] The FICI calculated for volatile oil was 0.467, 0.030, 0.132 for *S. typhi* samples, respectively, which indicates that volatile oil shows synergistic activity along with ciprofloxacin. The FICI was 0.038, 6.000, and 0.372, respectively, for phenolic fraction which demonstrates that for samples 1 and 3 phenolic fractions act synergistically; while for sample 2, it exhibits antagonistic activity when combined with ciprofloxacin and 16.525, 10.015, and 2.249, respectively, for nonphenolic fractions. FICI \> 4 of nonphenolic fraction for samples 1 and 2 explains its antagonistic behavior while indifferent for sample 3.
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The mechanisms by which volatile oil can inhibit microbes involve different modes of action and in part may be due to their hydrophobicity. As a result, they get partitioned into the lipid bilayer of the cell membrane, affecting the respiratory chain and the energy production,\[[@ref19]\] rendering it more permeable to the uptake of the antibiotics and leading to leakage of vital cell contents.\[[@ref20][@ref21]\]

CONCLUSION {#sec1-4}
==========

Results presented in this study reveal that *O. vulgare*, a culinary herb, can overcome multidrug resistance if used in antibiotic therapy along with lesser doses of synthetic antibiotics and may lessen the toxic effects of synthetic drugs.
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